Abstract
Zirconium-89 is currently being used in numerous clinical trials involving monoclonal antibodies and positron emission tomography. A comprehensively revised protocol for the production, quality control and long-term storage of 89 Zr-immuno-PET radiopharmaceuticals.
Funding Information
  • North Carolina Biotechnology Center (2016-BIG-6524)
  • National Center for Advancing Translational Sciences (UL1TR001420)

This publication has 76 references indexed in Scilit: